KLCM Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.67M | Buy |
166,141
+1,323
| +0.8% | +$35.2K | 0.39% | 49 |
|
|
2025
Q4 | $4.1M | Sell |
164,818
-10,001
| -6% | -$252K | 0.35% | 54 |
|
|
2025
Q3 | $4.45M | Sell |
174,819
-5,285
| -3% | -$130K | 0.44% | 41 |
|
|
2025
Q2 | $4.37M | Sell |
180,104
-4,499
| -2% | -$105K | 0.46% | 40 |
|
|
2025
Q1 | $4.68M | Sell |
184,603
-5,091
| -3% | -$133K | 0.55% | 40 |
|
|
2024
Q4 | $5.03M | Buy |
189,694
+57,984
| +44% | +$1.57M | 0.58% | 35 |
|
|
2024
Q3 | $3.81M | Buy |
131,710
+3,038
| +2% | +$88.6K | 0.45% | 38 |
|
|
2024
Q2 | $3.6M | Sell |
128,672
-51,267
| -28% | -$1.41M | 0.44% | 39 |
|
|
2024
Q1 | $4.99M | Buy |
179,939
+6,146
| +4% | +$171K | 0.64% | 33 |
|
|
2023
Q4 | $5M | Buy |
173,793
+74,487
| +75% | +$2.25M | 0.77% | 33 |
|
|
2023
Q3 | $3.29M | Buy |
99,306
+5,463
| +6% | +$193K | 0.62% | 39 |
|
|
2023
Q2 | $3.44M | Sell |
93,843
-3,372
| -3% | -$131K | 0.67% | 37 |
|
|
2023
Q1 | $3.97M | Buy |
97,215
+63,702
| +190% | +$2.75M | 0.79% | 34 |
|
|
2022
Q4 | $1.72M | Buy |
33,513
+3,889
| +13% | +$186K | 0.35% | 44 |
|
|
2022
Q3 | $1.3M | Buy |
29,624
+2,725
| +10% | +$132K | 0.3% | 50 |
|
|
2022
Q2 | $1.41M | Sell |
26,899
-1,694
| -6% | -$86.3K | 0.31% | 45 |
|
|
2022
Q1 | $1.48M | Sell |
28,593
-160,172
| -85% | -$8.31M | 0.31% | 43 |
|
|
2021
Q4 | $11.1M | Sell |
188,765
-8,782
| -4% | -$435K | 2.43% | 17 |
|
|
2021
Q3 | $8.5M | Sell |
197,547
-225,429
| -53% | -$9.99M | 1.83% | 21 |
|
|
2021
Q2 | $16.6M | Sell |
422,976
-43,878
| -9% | -$1.71M | 3.67% | 12 |
|
|
2021
Q1 | $16.9M | Buy |
466,854
+43,871
| +10% | +$1.56M | 3.84% | 9 |
|
|
2020
Q4 | $15.6M | Sell |
422,983
-10,729
| -2% | -$394K | 3.86% | 7 |
|
|
2020
Q3 | $15.1M | Sell |
433,712
-25,866
| -6% | -$907K | 4.4% | 4 |
|
|
2020
Q2 | $14.3M | Sell |
459,578
-34,198
| -7% | -$1.16M | 4.06% | 10 |
|
|
2020
Q1 | $15.3M | Buy |
493,776
+6,756
| +1% | +$230K | 4.84% | 7 |
|
|
2019
Q4 | $18.1M | Buy |
487,020
+15,009
| +3% | +$535K | 4.02% | 8 |
|
|
2019
Q3 | $16.1M | Buy |
472,011
+82,479
| +21% | +$3M | 4.1% | 10 |
|
|
2019
Q2 | $16M | Buy |
389,532
+3,500
| +0.9% | +$139K | 3.94% | 9 |
|
|
2019
Q1 | $15.6M | Buy |
386,032
+8,968
| +2% | +$359K | 3.83% | 10 |
|
|
2018
Q4 | $15.6M | Sell |
377,064
-6,236
| -2% | -$259K | 4.57% | 6 |
|
|
2018
Q3 | $16M | Sell |
383,300
-23,147
| -6% | -$891K | 3.94% | 10 |
|
|
2018
Q2 | $14M | Buy |
406,447
+5,158
| +1% | +$176K | 3.69% | 10 |
|
|
2018
Q1 | $13.5M | Sell |
401,289
-16,189
| -4% | -$557K | 3.66% | 10 |
|
|
2017
Q4 | $14.3M | Buy |
417,478
+2,268
| +0.5% | +$77.3K | 3.52% | 9 |
|
|
2017
Q3 | $14.1M | Sell |
415,210
-12,320
| -3% | -$396K | 3.67% | 9 |
|
|
2017
Q2 | $13.6M | Buy |
427,530
+14,903
| +4% | +$470K | 3.72% | 9 |
|
|
2017
Q1 | $13.4M | Buy |
412,627
+22,454
| +6% | +$708K | 3.78% | 9 |
|
|
2016
Q4 | $12M | Buy |
390,173
+188,900
| +94% | +$5.77M | 3.54% | 12 |
|
|
2016
Q3 | $6.47M | Buy |
201,273
+9,503
| +5% | +$318K | 2.06% | 21 |
|
|
2016
Q2 | $6.41M | Buy |
191,770
+183,084
| +2,108% | +$5.84M | 2.22% | 20 |
|
|
2016
Q1 | $244K | Buy |
8,686
+316
| +4% | +$9.03K | 0.08% | 63 |
|
|
2015
Q4 | $256K | Sell |
8,370
-14,551
| -63% | -$458K | 0.09% | 56 |
|
|
2015
Q3 | $683K | Sell |
22,921
-4,511
| -16% | -$145K | 0.24% | 34 |
|
|
2015
Q2 | $873K | Buy |
27,432
+2,554
| +10% | +$83.2K | 0.22% | 30 |
|
|
2015
Q1 | $821K | Sell |
24,878
-1,840
| -7% | -$58.5K | 0.23% | 30 |
|
|
2014
Q4 | $790K | Buy |
26,718
+654
| +3% | +$18.8K | 0.2% | 34 |
|
|
2014
Q3 | $731K | Buy |
26,064
+1,530
| +6% | +$42.9K | 0.19% | 34 |
|
|
2014
Q2 | $691K | Hold |
24,534
| – | – | 0.16% | 38 |
|
|
2014
Q1 | $748K | Hold |
24,534
| – | – | 0.2% | 34 |
|
|
2013
Q4 | $713K | Sell |
24,534
-268
| -1% | -$7.8K | 0.19% | 34 |
|
|
2013
Q3 | $676K | Buy |
24,802
+268
| +1% | +$7.29K | 0.19% | 35 |
|
|
2013
Q2 | $652K | Buy |
+24,534
| New | +$678K | 0.21% | 35 |
|
Other funds holding PFE
VCM
VPM
KLCM Advisors's PFE Position: Q1 2026 in Review
KLCM Advisors increased its Pfizer (PFE) stake by 0.8% in Q1 2026, buying an estimated $35.2K and bringing the position to 166,141 shares worth $4.67M. The position accounts for 0.39% of the portfolio, ranked #49.
KLCM Advisors first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $18.1M in Q4 2019. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- KLCM Advisors held 166,141 shares of Pfizer worth $4.67M as of Q1 2026.
- KLCM Advisors bought 1,323 Pfizer shares in Q1 2026, an estimated $35.2K.
- Pfizer made up 0.39% of KLCM Advisors's portfolio in Q1 2026, its #49 holding.
- KLCM Advisors first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- KLCM Advisors's Pfizer position peaked at $18.1M in Q4 2019.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on KLCM Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.